Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

PhaseBio to Announce PB2452, a Novel Reversal Agent for Antiplatelet Drug Ticagrelor

PhaseBio Pharmaceuticals is planning to announce PB a novel reversal agent for the Antiplatelet drug Ticagrelor PB is a novel recombinant human monoclonal antibody antigenbinding fragment or Fab fragment designed to reverse the Antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations

NUS Chemists Develop Novel Ratiometric Fluorescent Probe

NUS chemists have developed a novel ratiometric fluorescent probe known as RDC for studying cellular activity of the clinically important anticancer drug cisplatin for next generation drug development

Nottingham University Launches First-of-its-kind Equipment for Chemical Imaging of Materials, Cells & Tissues

The University of Nottingham launched unique firstofitskind equipment DOrbiSIMS which allows labelfree chemical imaging of materials cells and tissues with the potential to transform research in these areas DOrbiSIMS will have applications in a multidisciplinary range of research areas These areas include biomedical implants drug delivery system...

Researchers Develop DNA-encoded PCSK9 Inhibitors to Regulate Cholesterol Levels in Bloodstream

The Wistar Institute researchers have developed novel synthetic DNAencoded Monoclonal Antibodies DMAbs directed against PCSK a protein key to regulating cholesterol levels in the bloodstream A preclinical study showed a significant cholesterol decrease helping for the development of this approach as a simple less frequent and costeffective thera...

Molecule Discovery Shows Promise for Gene Therapy for Skin Diseases

University of Birmingham scientists announced the discovery of a protein that could hold the key to novel therapies for skin problems such as psoriasis The newly discovered protein which is a fragment of a larger molecule called JARID was present to only be present in the developing embryo where it coordinates the formation of tissues and organs...

Mount Sinai Researchers Determine Significant Beta Cell Proliferation Using Combination of Pharmacologic and Genetic Inhibition

Mount Sinai Researchers determines a significant beta cell proliferation using combination of pharmacologic and genetic inhibition They have discovered a novel combination of two classes of drugs that induces the highest rate of proliferation in adult human beta cells the cells that produce insulin in the pancreas The result will help for th...

Novartis Promacta® Approved as First-Line Treatment for Severe Aplastic Anemia(SAA)

Novartis Promacta is approved as the firstline treatment for adults and pediatric patients two years and older with Severe Aplastic Anemia SAA in combination with standard immunosuppressive therapy IST Promacta is an oral thrombopoietin receptor agonist TPORA that is already approved for SAA for patients who have had an insufficient response to...

NRX-101 Represents New Class of Antidepressants to Decrease Suicidal Thoughts

NeuroRxs NRX the first oral drug targeting suicidal bipolar depression helps to treat severe bipolar depression with Acute Suicidal Ideation Behavior ASIB NRX is used for treatment of Severe Bipolar Depression with Acute Suicidal Ideation Behaviour after initial stabilisation with ketamine or other effective therapy NRX Dcycloserinelurasido...

Researchers Design and Develop New Class of Molecules to Halt Tumors

Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a neverbeforeknown mechanism that may halt or destroy breast cancer tumors This mechanism can be used for patients with drugresistant or dangerously metastatic stages of the disease The molecule developed by the scientis...

Insmed Announces ARIKAYCE® For the Treatment of Mycobacterium Avium Complex (MAC) Lung Disease

Insmed Inc announced ARIKAYCE amikacin liposome inhalation suspension for the treatment of Mycobacterium Avium Complex MAC lung disease as part of a combination antibacterial drug regimen for adult patients ARIKAYCE can be used for patients with MAC lung disease a chronic and debilitating condition that can significantly increase patient morbidi...

AirBridgeCargo - Air frieght solutions for your Pharma ACG’s Packdoctors - Get your common packaging problems treated ACG - Myanmar Pharma Matcon Efficently handling tablets and powders in IBC's MECO - 90 Years